lopinavir (Aluviran)

Introduction

Major anti-retroviral protease activity in combination with ritonavir in Kaletra (combination antiretroviral agent).

Indications

• HIV1 infection

Adverse effects

• nausea
• diarrhea
• hyperlipidemia
• insulin resistance

• drug adverse effects of antiretroviral protease inhibitors
• drug adverse effects of antiretroviral agents

Laboratory

• lopinavir in serum/plasma

More general terms

• antiretroviral protease inhibitor

Component of

• lopinavir/ritonavir (Kaletra)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=92727